Skip to main content

The Client

The Motor Neurone Disease Association is a membership (and campaigning) organisation with over 10,000 members forming a powerful national and local network that funds and promotes research, provides information and support for people living with Motor Neurone Disease (MND) and their families. MNDA has 7,000 active volunteers in England, Wales and Northern Ireland and around 180 paid staff, all dedicated to improving the lives of people affected by MND, and the Association has an income or c£18.6 million.

Key Objectives

The Association engaged Oxford HR to find a Chair-Elect, who would succeed the current Chair in 2022.

Whilst the appointed individual may not have direct experience of MND, they would be required to show they can represent those who are living with a diagnosis of MND, their families and support groups, with credibility and thoughtful compassion. 

Services

  • Executive Search
  • Board & Advisory
MNDA volunteer

The ideal individual would bring to the Board energy,  progressive approaches, dynamic leadership skills while ensuring the strengths and values of the association remain intact. Representing their members, the incoming Chair-Elect was required to build relationships, not just with the Board, Executive, partner organisations, networks but also with the regional groups and branches – the Chairs and volunteers who lead these groups.  

Whilst the appointed individual may not have direct experience of MND, they would be required to show they can represent those who are living with a diagnosis of MND, their families and support groups, with credibility and thoughtful compassion. 

This project was taking place during the Covid-19 pandemic, and the associated challenges. To support the search Oxford HR devised a robust cohort of briefing meetings, speaking with a wide range of stakeholders, Board members, staff and Branch Chairs.

We have traditionally recruited our Chair-Elect from within our existing membership and supporters. This has served us well in the past, but as we plan for a new ambitious strategy, to capitalise on digital breakthroughs that may help people living with MND, seek to involve our members even more in developing our Association, and as we near closer and closer to potential treatments for MND; we wanted to bring new skills and perspectives into our strategic thinking. The role of the Chair will be pivotal in our future development, so we sought the help of OxfordHR to widen our reach to potential candidates outside as well as within our existing networks.

The team was able to not only reach new potential candidates, but also brought their experience to bear in briefing those interested in our Association and longlisting the candidates. There is a lot of work involved in coordinating such a process, if we are to provide a thorough analysis of each candidate’s strengths, and Sarah and team helped do much of that heavy lifting. However, she kept our team closely engaged and informed throughout so that it always felt like a collaborative initiative rather than a service provided to us. The team was able to not only reach new potential candidates, but also brought their experience to bear in briefing those interested in our Association and longlisting the candidates.

Richard Coleman and Sally LightMotor Neurone Disease Association’s Chair & CEO
Usman Khan, MNDA

Oxford HR was careful to offer an inclusive process, adapting the process for candidates who required more support, and offering advice and guidance to support the Appointing Panel in the decision making process. Four diverse, high calibre professionals were interviewed at the final stage, with two candidates ultimately considered for the role of Chair-Elect.  

We were delighted to support the Association in the appointment of the Chair-Elect, who is a governance expert, senior advisor to FIPRA International and experienced Chair (previous Chair of Turning Point); serving on the Board of a North London NHS Trust for many years, and leading the European Health Management Association, and European Patients Forum in his executive career.